{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:08:58Z","timestamp":1789088938803,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-026-00659-3","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:25:09Z","timestamp":1782383109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of metformin as an adjunctive therapy in rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"10","author":[{"given":"Manar M.","family":"Alshammari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor A.","family":"Abood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundus","family":"Kahwaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sharif-Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Alobaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelal","family":"Kharaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras","family":"Jirjees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"659_CR1","doi-asserted-by":"publisher","first-page":"1003208","DOI":"10.37349\/ei.2025.1003208","volume":"5","author":"V Kasiraja","year":"2025","unstructured":"Kasiraja V, Bakar NAA, Suliman NA. Rheumatoid arthritis unmasked: the immune complex as a key driver of disease progression. Explor Immunol. 2025;5:1003208. https:\/\/doi.org\/10.37349\/ei.2025.1003208.","journal-title":"Explor Immunol"},{"issue":"3","key":"659_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mpmed.2021.12.002","volume":"50","author":"M Colquhoun","year":"2022","unstructured":"Colquhoun M, Gulati M, Farah Z, Mouyis M. Clinical features of rheumatoid arthritis. Med (Baltim). 2022;50(3):138\u201342. https:\/\/doi.org\/10.1016\/j.mpmed.2021.12.002.","journal-title":"Med (Baltim)"},{"issue":"4","key":"659_CR3","first-page":"286","volume":"5","author":"M Cojocaru","year":"2010","unstructured":"Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular Manifestations in Rheumatoid Arthritis. Maedica. 2010;5(4):286\u201391.","journal-title":"Maedica"},{"issue":"1","key":"659_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.path.2019.11.005","volume":"13","author":"JJ Schulte","year":"2020","unstructured":"Schulte JJ, Husain AN. Connective Tissue Disease Related Interstitial Lung Disease. Surg Pathol Clin. 2020;13(1):165\u201388. https:\/\/doi.org\/10.1016\/j.path.2019.11.005.","journal-title":"Surg Pathol Clin"},{"issue":"4","key":"659_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","volume":"166","author":"CS Crowson","year":"2013","unstructured":"Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, Hlatky MA, Gabriel SE. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013;166(4):622\u2013e6281. https:\/\/doi.org\/10.1016\/j.ahj.2013.07.010.","journal-title":"Am Heart J"},{"key":"659_CR6","unstructured":"Rheumatoid arthritis. 2023. World Health Organization. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rheumatoid-arthritis."},{"issue":"1","key":"659_CR7","doi-asserted-by":"publisher","first-page":"10736","DOI":"10.1038\/s41598-025-92150-1","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA. The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies. J Rheumatol. 2021;48(5):669\u201376. https:\/\/doi.org\/10.1038\/s41598-025-92150-1.","journal-title":"Sci Rep"},{"issue":"5","key":"659_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3899\/jrheum.200367","volume":"48","author":"KB Almutairi","year":"2021","unstructured":"Zhang Z, Gao X, Liu S, Wang Q, Wang Y, Hou S, Wang J, Zhang Y. Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20\u201354 years from 1990 to 2021. Sci Rep. 2025;15(1):10736. https:\/\/doi.org\/10.1038\/s41598-025-92150-1.","journal-title":"J Rheumatol"},{"issue":"1","key":"659_CR9","doi-asserted-by":"publisher","first-page":"102036","DOI":"10.1016\/j.berh.2025.102036","volume":"39","author":"P Uke","year":"2025","unstructured":"Uke P, Maharaj A, Adebajo A. A review on the epidemiology of rheumatoid arthritis: An update and trends from current literature. Best Pract Res Clin Rheumatol. 2025;39(1):102036. https:\/\/doi.org\/10.1016\/j.berh.2025.102036.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"659_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.20471\/acc.2019.58.01.20","volume":"58","author":"R Martinec","year":"2019","unstructured":"Martinec R, Pinjatela R, Balen D. Quality of Life in Patients with Rheumatoid Arthritis \u2013 a Preliminary Study. Acta Clin Croat. 2019;58(1):157\u201366. https:\/\/doi.org\/10.20471\/acc.2019.58.01.20.","journal-title":"Acta Clin Croat"},{"issue":"1","key":"659_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.berh.2004.08.007","volume":"19","author":"D Scott","year":"2005","unstructured":"Scott D, Smith C, Kingsley G. What are the consequences of early rheumatoid arthritis for the individual? Best Pract Res Clin Rheumatol. 2005;19(1):117\u201336. https:\/\/doi.org\/10.1016\/j.berh.2004.08.007.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10055","key":"659_CR12","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8.","journal-title":"Lancet"},{"issue":"43","key":"659_CR13","doi-asserted-by":"publisher","first-page":"e40221","DOI":"10.1097\/MD.0000000000040221","volume":"103","author":"S Mohamed","year":"2024","unstructured":"Mohamed S, Metformin. Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review. Med (Baltim). 2024;103(43):e40221. https:\/\/doi.org\/10.1097\/MD.0000000000040221.","journal-title":"Med (Baltim)"},{"issue":"1","key":"659_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3904\/kjim.2021.363","volume":"37","author":"JW Kim","year":"2022","unstructured":"Kim JW, Choe JY, Park SH. Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease. Korean J Intern Med. 2022;37(1):13\u201326. https:\/\/doi.org\/10.3904\/kjim.2021.363.","journal-title":"Korean J Intern Med"},{"issue":"3","key":"659_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/03009742.2019.1695928","volume":"49","author":"M Naffaa","year":"2020","unstructured":"Naffaa M, Rosenberg V, Watad A, Tiosano S, Yavne Y, Chodick G, Amital H, Shalev V. Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study. Scand J Rheumatol. 2020;49(3):173\u201380. https:\/\/doi.org\/10.1080\/03009742.2019.1695928.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"659_CR16","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.3390\/jcm12072461","volume":"12","author":"J Liang","year":"2023","unstructured":"Liang J, Cai Y, Zhang J, Jing Z, Lv L, Zhang G, Zhang R, Liu R, Nan K, Dang X. Metformin Treatment Reduces the Incidence of Rheumatoid Arthritis: A Two-Sample Mendelian Randomized Study. J Clin Med. 2023;12(7):2461. https:\/\/doi.org\/10.3390\/jcm12072461.","journal-title":"J Clin Med"},{"key":"659_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"659_CR18","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024. Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current."},{"issue":"6","key":"659_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/emermed-2020-209567","volume":"37","author":"M Amir-Behghadami","year":"2020","unstructured":"Amir-Behghadami M, Janati A, Population. Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020;37(6):387\u2013387. https:\/\/doi.org\/10.1136\/emermed-2020-209567.","journal-title":"Emerg Med J"},{"key":"659_CR20","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"11","key":"659_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"issue":"4","key":"659_CR22","first-page":"2034","volume":"15","author":"DS Kumar","year":"2024","unstructured":"Kumar DS, Bharti DN, Haque DSMI, Singh DA. To determine the effectiveness of Metformin in treating Rheumatoid Arthritis at a Tertiary Care Centre: A Randomized Controlled Study. J Cardiovasc Dis Res. 2024;15(4):2034\u201342Kumar DS, Bharti DN, Haque DSMI, Singh DA. To determine the effectiveness of Metformin in treating Rheumatoid Arthritis at a Tertiary Care Centre: A Randomized Controlled Study. J Cardiovasc Dis Res. 2024;15(4):2034\u201342. Available from https:\/\/www.jcdronline.org\/index.php\/JCDR\/article\/view\/11717.","journal-title":"J Cardiovasc Dis Res"},{"key":"659_CR23","doi-asserted-by":"publisher","first-page":"107575","DOI":"10.1016\/j.intimp.2021.107575","volume":"95","author":"MS Abdallah","year":"2021","unstructured":"Abdallah MS, Alarfaj SJ, Saif DS, EL-Naggar ME, Elsokary MA, Elsawah HK, Abdelsattar Zaki S, Wahsh EA, Abo Mansour HE, Mosalam EM. The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial. Int Immunopharmacol. 2021;95:107575. https:\/\/doi.org\/10.1016\/j.intimp.2021.107575.","journal-title":"Int Immunopharmacol"},{"key":"659_CR24","doi-asserted-by":"publisher","first-page":"726490","DOI":"10.3389\/fphar.2021.726490","volume":"12","author":"M Gharib","year":"2021","unstructured":"Gharib M, Elbaz W, Darweesh E, Sabri NA, Shawki MA. Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study. Front Pharmacol. 2021;12:726490. https:\/\/doi.org\/10.3389\/fphar.2021.726490.","journal-title":"Front Pharmacol"},{"issue":"8","key":"659_CR25","first-page":"402","volume":"15","author":"M Kumar","year":"2023","unstructured":"Kumar M, Singh A, Kumar N, Haque SMI. The Study of the Efficacy of Metformin in Rheumatoid Arthritis and its Effect on Serum C-Reactive Protein at a Tertiary Centre. Int J Health Clin Res. 2023;15(8):402\u2013207.","journal-title":"Int J Health Clin Res"},{"issue":"6","key":"659_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"DT Felson","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38(6):727\u201335. https:\/\/doi.org\/10.1002\/art.1780380602.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"659_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/XCE.0000000000000244","volume":"10","author":"Z Tian","year":"2021","unstructured":"Tian Z, Mclaughlin J, Verma A, Chinoy H, Heald AH. The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Endocrinol Metab. 2021;10(2):125\u201331. https:\/\/doi.org\/10.1097\/XCE.0000000000000244.","journal-title":"Cardiovasc Endocrinol Metab"},{"issue":"4","key":"659_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/acr.23611","volume":"71","author":"JC Wilson","year":"2019","unstructured":"Wilson JC, Sarsour K, Gale S, Peth\u00f6-Schramm A, Jick SS, Meier CR. Incidence and Risk of Glucocorticoid\u2010Associated Adverse Effects in Patients With Rheumatoid Arthritis. Arthritis Care Res. 2019;71(4):498\u2013511. https:\/\/doi.org\/10.1002\/acr.23611.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"659_CR29","doi-asserted-by":"publisher","first-page":"17437","DOI":"10.1038\/s41598-019-53505-7","volume":"9","author":"R Hamoudi","year":"2019","unstructured":"Hamoudi R, Saheb Sharif-Askari N, Saheb Sharif-Askari F, Abusnana S, Aljaibeji H, Taneera J, Sulaiman N. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. Sci Rep. 2019;9(1):17437. https:\/\/doi.org\/10.1038\/s41598-019-53505-7.","journal-title":"Sci Rep"},{"issue":"2","key":"659_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"659_CR31","first-page":"653","volume":"4","author":"H Mahdi","year":"2013","unstructured":"Mahdi H, Hassan Y, Abdul Aziz N, AbdulRazaq H, Jirjees F, Abdulkareem A. Diabetes knowledge and practice in Malaysian and the United Arab Emirates diabetic patients. Res J Pharm Biol Chem Sci. 2013;4(3):653\u201365.","journal-title":"Res J Pharm Biol Chem Sci"},{"issue":"8","key":"659_CR32","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147(8):e93\u2013621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123.","journal-title":"Circulation"},{"key":"659_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/973986","volume":"2014","author":"HJ Son","year":"2014","unstructured":"Son HJ, Lee J, Lee SY, Kim EK, Park MJ, Kim KW, Park SH, Cho ML. Metformin Attenuates Experimental Autoimmune Arthritis through Reciprocal Regulation of Th17\/Treg Balance and Osteoclastogenesis. Mediators Inflamm. 2014;2014:1\u201313. https:\/\/doi.org\/10.1155\/2014\/973986.","journal-title":"Mediators Inflamm"},{"key":"659_CR34","doi-asserted-by":"publisher","first-page":"108875","DOI":"10.1016\/j.biopha.2019.108875","volume":"115","author":"K Chen","year":"2019","unstructured":"Chen K, Lin ZW, He S, mao, Wang C, qiang, Yang JC, Lu Y, Xie XB, Li Q. Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR\/PI3K\/AKT\/m-TOR pathway. Biomed Pharmacother. 2019;115:108875. https:\/\/doi.org\/10.1016\/j.biopha.2019.108875.","journal-title":"Biomed Pharmacother"},{"key":"659_CR35","doi-asserted-by":"publisher","first-page":"6778332","DOI":"10.1155\/2022\/6778332","volume":"2022","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zige L, Sai Kiang Y, Desheng C. Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride. Int J Endocrinol. 2022;2022:6778332. https:\/\/doi.org\/10.1155\/2022\/6778332.","journal-title":"Int J Endocrinol"},{"key":"659_CR36","doi-asserted-by":"publisher","first-page":"777450","DOI":"10.3389\/fcell.2021.777450","volume":"9","author":"LY Tao","year":"2022","unstructured":"Tao LY, \u0141agosz-\u0106wik KB, Hogervorst JMA, Schoenmaker T, Grabiec AM, Forouzanfar T, van der Weijden FA, de Vries TJ. Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis. Front Cell Dev Biol. 2022;9:777450. https:\/\/doi.org\/10.3389\/fcell.2021.777450.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"659_CR37","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1002\/jcb.23206","volume":"112","author":"QG Mai","year":"2011","unstructured":"Mai QG, Zhang ZM, Xu S, Lu M, Zhou RP, Zhao L, Jia CH, Wen ZH, Jin DD, Bai XC. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem. 2011;112(10):2902\u20139. https:\/\/doi.org\/10.1002\/jcb.23206.","journal-title":"J Cell Biochem"},{"issue":"23","key":"659_CR38","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.21037\/atm-20-3042","volume":"8","author":"KJ Fan","year":"2020","unstructured":"Fan KJ, Wu J, Wang QS, Xu BX, Zhao FT, Wang TY. Metformin inhibits inflammation and bone destruction in collagen-induced arthritis in rats. Ann Transl Med. 2020;8(23):1565. https:\/\/doi.org\/10.21037\/atm-20-3042.","journal-title":"Ann Transl Med"},{"issue":"1","key":"659_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","volume":"16","author":"KY Kang","year":"2013","unstructured":"Kang KY, Kim YK, Yi H, Kim J, Jung HR, Kim IJ, Cho JH, Park SH, Kim HY, Ju JH. Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis. Int Immunopharmacol. 2013;16(1):85\u201392. https:\/\/doi.org\/10.1016\/j.intimp.2013.03.020.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"659_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/08923973.2015.1122619","volume":"38","author":"J Jhun","year":"2016","unstructured":"Jhun J, Lee S, Kim SY, Na HS, Kim EK, Kim JK, Jeong JH, Park SH, Cho ML. Combination therapy with metformin and coenzyme Q10 in murine experimental autoimmune arthritis. Immunopharmacol Immunotoxicol. 2016;38(2):103\u201312. https:\/\/doi.org\/10.3109\/08923973.2015.1122619.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"659_CR41","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1038\/emm.2017.245","volume":"50","author":"EK Kim","year":"2018","unstructured":"Kim EK, Lee SH, Lee SY, Kim JK, Jhun JY, Na HS, Kim SY, Choi JY, Yang CW, Park SH, Cho ML. Metformin ameliorates experimental-obesity-associated autoimmune arthritis by inducing FGF21 expression and brown adipocyte differentiation. Exp Mol Med. 2018;50(1):e432. https:\/\/doi.org\/10.1038\/emm.2017.245.","journal-title":"Exp Mol Med"},{"issue":"9","key":"659_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3949\/ccjm.90a.22096","volume":"90","author":"P Rodriguez","year":"2023","unstructured":"Rodriguez P, Pantalone KM, Griebeler ML, Burguera B. Should I consider metformin therapy for weight loss in patients with obesity but without diabetes? Cleve Clin J Med. 2023;90(9):545\u20138. https:\/\/doi.org\/10.3949\/ccjm.90a.22096.","journal-title":"Cleve Clin J Med"},{"issue":"S3","key":"659_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/dom.15729","volume":"26","author":"A Solini","year":"2024","unstructured":"Solini A, Tric\u00f2 D. Clinical efficacy and cost-effectiveness of metformin in different patient populations: A narrative review of real\u2010world evidence. Diabetes Obes Metab. 2024;26(S3):20\u201330. https:\/\/doi.org\/10.1111\/dom.15729.","journal-title":"Diabetes Obes Metab"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00659-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00659-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00659-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:26:23Z","timestamp":1789086383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00659-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["659"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00659-3","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The results\/data\/figures in this manuscript have not been published elsewhere, nor are they under consideration (from you or one of your Contributing Authors) by another publisher. I confirm the corresponding author has read the journal policies and submitted this manuscript in accordance with those policies. All of the material is owned by the authors and\/or no permissions are required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript was written entirely by the authors. An AI-assisted tool like ChatGPT was used in selected portions of the manuscript to improve the clarity and readability of the text. The tool was not used to generate original scientific content, analyze data, or draw conclusions. All outputs were carefully reviewed and approved by the authors, who take full responsibility for the manuscript.","order":3,"name":"Ethics","label":"Use of AI and AI-Assisted Technologies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}